Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANI PHARMACEUTICALS INCANIP · Entity 4638 | SVP & CFO | September 29, 2026 | September 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANI PHARMACEUTICALS INC
Report date September 29, 2026 · Filed September 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 168,993 |
Reported balance
After 2026-09-29 transaction · row 1
1 source rowRow 1 · 2026-09-29 · Sale · Disposed 2,850 · Balance 168,993 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2: The shares were sold in multiple trades at prices ranging from $72.57 to $73.86. The price reported above reflects the weighted average sales price. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
F2: The shares were sold in multiple trades at prices ranging from $72.57 to $73.86. The price reported above reflects the weighted average sales price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 29, 2026 Filed Sep 30, 2026 20:52 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 2,850 | $73.00 | $208,050.00 |
DisclosureSEC source: 0001674236-26-000024 · wk-form4_1790801532.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,993 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2 · price: The shares were sold in multiple trades at prices ranging from $72.57 to $73.86. The price reported above reflects the weighted average sales price. Read SEC document |
| August 31, 2026 Filed Sep 1, 2026 22:18 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 2,850 | $72.80 | $207,480.00 |
DisclosureSEC source: 0001674236-26-000022 · wk-form4_1788301118.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,843 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2 · price: The shares were sold in multiple trades at prices ranging from $71.89 to $73.36. The price reported above reflects the weighted average sales price. Read SEC document |
| July 29, 2026 Filed Jul 30, 2026 20:02 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 2,850 | $81.36 | $231,876.00 |
DisclosureSEC source: 0001674236-26-000019 · wk-form4_1785441772.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 174,693 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2 · price: The shares were sold in multiple trades at prices ranging from $80.61 to $81.88. The price reported above reflects the weighted average sales price. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 01:40 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionStock Option (right to buy) · Derivative | 3,313 | $49.51 Strike: $49.51 | $164,026.63 |
DisclosureSEC source: 0001674236-26-000017 · wk-form4_1783388415.xml · derivative · entry 3 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,313 Underlying: Common Stock · 3,313 shares Expires 2027-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2 · derivative.exercise_date: 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 01:40 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 3,313 | $86.00 | $284,918.00 |
DisclosureSEC source: 0001674236-26-000017 · wk-form4_1783388415.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,543 F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 01:40 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionCommon Stock | 3,313 | $49.51 | $164,026.63 |
DisclosureSEC source: 0001674236-26-000017 · wk-form4_1783388415.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. Read SEC document |
| June 29, 2026 Filed Jun 30, 2026 20:14 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 2,850 | $84.12 | $239,742.00 |
DisclosureSEC source: 0001674236-26-000015 · wk-form4_1782850477.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 177,543 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2 · price: The shares were sold in multiple trades at prices ranging from $83.39 to $84.63. The price reported above reflects the weighted average sales price. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 22:33 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionStock Option (right to buy) · Derivative | 3,312 | $49.51 Strike: $49.51 | $163,977.12 |
DisclosureSEC source: 0001674236-26-000013 · wk-form4_1781044421.xml · derivative · entry 3 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,626 Underlying: Common Stock · 3,312 shares Expires 2027-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. F2 · derivative.exercise_date: 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 22:33 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 3,312 | $80.00 | $264,960.00 |
DisclosureSEC source: 0001674236-26-000013 · wk-form4_1781044421.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 180,393 F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 22:33 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionCommon Stock | 3,312 | $49.51 | $163,977.12 |
DisclosureSEC source: 0001674236-26-000013 · wk-form4_1781044421.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 183,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. Read SEC document |
| March 07, 2026 Filed Mar 10, 2026 20:04 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 5,150 | $74.04 | $381,306.00 |
DisclosureSEC source: 0001674236-26-000010 · wk-form4_1773173079.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,393 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,292 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 22:46 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionStock Option (right to buy) · Derivative | 3,312 | $49.51 Strike: $49.51 | $163,977.12 |
DisclosureSEC source: 0001674236-26-000008 · wk-form4_1772750785.xml · derivative · entry 4 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,938 Underlying: Common Stock · 3,312 shares Expires 2027-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 22:46 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 4,000 | $75.56 | $302,240.00 |
DisclosureSEC source: 0001674236-26-000008 · wk-form4_1772750785.xml · nonDerivative · entry 3 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,543 Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 22:46 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 3,312 | $75.42 | $249,791.04 |
DisclosureSEC source: 0001674236-26-000008 · wk-form4_1772750785.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,543 F1 · price: The shares were sold in multiple trades at prices ranging from $75.41 to $75.56. The price reported above reflects the weighted average sales price. Read SEC document |
| March 05, 2026 Filed Mar 5, 2026 22:46 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionCommon Stock | 3,312 | $49.51 | $163,977.12 |
DisclosureSEC source: 0001674236-26-000008 · wk-form4_1772750785.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2026 Filed Mar 2, 2026 22:57 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 2,773 | $73.90 | $204,924.70 |
DisclosureSEC source: 0001674236-26-000006 · wk-form4_1772492247.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,543 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,079 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:57 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 22,233 | $77.15 | $1,715,275.95 |
DisclosureSEC source: 0001674236-26-000006 · wk-form4_1772492247.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,316 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026. Read SEC document |
| February 14, 2026 Filed Feb 17, 2026 21:03 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 2,448 | $77.36 | $189,377.28 |
DisclosureSEC source: 0001674236-26-000004 · wk-form4_1771362205.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,083 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,368 shares of restricted stock, the grant of which was previously reported on February 16, 2024. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:03 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 2,829 | $76.70 | $216,984.30 |
DisclosureSEC source: 0001674236-26-000004 · wk-form4_1771362205.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,531 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,202 shares of restricted stock, the grant of which was previously reported on February 18, 2025. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:13 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 5,503 | $76.25 | $419,603.75 |
DisclosureSEC source: 0001674236-26-000002 · wk-form4_1771017231.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,360 F1 · shares: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 16,210 performance stock units, the grant of which was previously reported on April 6, 2023. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 21:40 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $46.49 Strike: $46.49 | $2,324,500.00 |
DisclosureSEC source: 0001674236-25-000010 · wk-form4_1755207652.xml · derivative · entry 3 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2026-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 25% of the total options vested on each of May 6, 2017, May 6, 2018, May 6, 2019, and May 6, 2020. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 21:40 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 50,000 | $86.07 | $4,303,500.00 |
DisclosureSEC source: 0001674236-25-000010 · wk-form4_1755207652.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,863 Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 21:40 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Exercise / conversionCommon Stock | 50,000 | $46.49 | $2,324,500.00 |
DisclosureSEC source: 0001674236-25-000010 · wk-form4_1755207652.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 23, 2025 Filed Mar 25, 2025 20:44 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 6,210 | $64.26 | $399,054.60 |
DisclosureSEC source: 0001674236-25-000008 · wk-form4_1742935483.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,863 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 13,618 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2025 Filed Mar 14, 2025 21:17 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 5,150 | $60.62 | $312,193.00 |
DisclosureSEC source: 0001674236-25-000006 · wk-form4_1741987072.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,073 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,292 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:03 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,861 | $61.89 | $115,177.29 |
DisclosureSEC source: 0001674236-25-000004 · wk-form4_1741125785.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,223 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,079 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 01:11 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,730 | $58.92 | $101,931.60 |
DisclosureSEC source: 0001674236-25-000002 · wk-form4_1739927467.xml · nonDerivative · entry 3 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,084 F3 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 5,368 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:11 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 16,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001674236-25-000002 · wk-form4_1739927467.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,814 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 12, 2025 Filed Feb 19, 2025 01:11 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 24,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001674236-25-000002 · wk-form4_1739927467.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,276 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025. Read SEC document |
| December 17, 2024 Filed Dec 18, 2024 22:59 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 7,500 | $55.79 | $418,425.00 |
DisclosureSEC source: 0001674236-24-000015 · wk-form4_1734562739.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,468 F1 · price: The shares were sold in multiple trades at prices ranging from $55.29 to $56.30. The price reported above reflects the weighted average sales price. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 11:34 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 5,000 | $63.58 | $317,900.00 |
DisclosureSEC source: 0001674236-24-000013 · wk-form4_1717673646.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,968 F1 · price: The shares were sold in multiple trades at prices ranging from $64.85 to $62.72. The price reported above reflects the weighted average sales price. Read SEC document |
| April 10, 2024 Filed Apr 12, 2024 01:12 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 4,534 | $66.96 | $303,596.64 |
DisclosureSEC source: 0001674236-24-000011 · wk-form4_1712884344.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,968 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 9,942 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 23, 2024 Filed Mar 25, 2024 20:17 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 6,210 | $69.58 | $432,091.80 |
DisclosureSEC source: 0001674236-24-000009 · wk-form4_1711397817.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,502 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 13,618 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 11, 2024 Filed Mar 11, 2024 22:39 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 7,787 | $65.55 | $510,437.85 |
DisclosureSEC source: 0001674236-24-000007 · wk-form4_1710196767.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,712 F2 · price: The shares were sold in multiple trades at prices ranging from $65.08 to $66.63. The price reported above reflects the weighted average sales price. Read SEC document |
| March 07, 2024 Filed Mar 11, 2024 22:39 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 4,216 | $66.71 | $281,249.36 |
DisclosureSEC source: 0001674236-24-000007 · wk-form4_1710196767.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,499 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,292 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 21:55 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,914 | $67.67 | $129,520.38 |
DisclosureSEC source: 0001674236-24-000005 · wk-form4_1709330090.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,715 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,079 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:26 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 14,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001674236-24-000003 · wk-form4_1708118772.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,629 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 21:26 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 21,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001674236-24-000003 · wk-form4_1708118772.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,313 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 20:24 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | SaleCommon Stock | 17,639 | $61.37 | $1,082,505.43 |
DisclosureSEC source: 0001674236-23-000004 · wk-form4_1692217456.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,839 F1 · price: Reflects the weighted average price of sales on August 14, 2023. The shares were sold in multiple transactions at prices ranging from $60.50 to $61.86, inclusive. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 20:43 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 4,534 | $38.50 | $174,559.00 |
DisclosureSEC source: 0001104659-23-044638 · tm2312564-2_4seq1.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,478 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 9,942 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 28, 2023 Filed Mar 31, 2023 00:00 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,420 | $38.62 | $54,840.40 |
DisclosureSEC source: 0001104659-23-039338 · tm2311020-1_4seq1.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP AND CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,486 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,113 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 23, 2023 Filed Mar 28, 2023 00:00 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 4,224 | $37.82 | $159,751.68 |
DisclosureSEC source: 0001104659-23-037249 · tm2310677-1_4seq1.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP AND CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,906 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 13,617 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:45 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 864 | $44.23 | $38,214.72 |
DisclosureSEC source: 0001104659-23-030708 · tm239061-3_4seq1.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,130 F2 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,822 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 07, 2023 Filed Mar 9, 2023 23:45 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 2,639 | $44.23 | $116,722.97 |
DisclosureSEC source: 0001104659-23-030708 · tm239061-3_4seq1.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,994 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,468 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| February 28, 2023 Filed Apr 7, 2023 00:00 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 16,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-042847 · tm2311710-1_4seq1.xml · nonDerivative · entry 2 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,012 F2 · kind: These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting. Read SEC document |
| February 28, 2023 Filed Apr 7, 2023 00:00 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 24,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-042847 · tm2311710-1_4seq1.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,802 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 22:34 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | GrantCommon Stock | 11,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-004405 · form4-04292022_030455.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,633 F1 · kind: Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of March 7, 2022. Read SEC document |
| April 10, 2022 Filed Apr 12, 2022 21:11 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 4,534 | $29.91 | $135,611.94 |
DisclosureSEC source: 0001415889-22-004020 · form4-04122022_020415.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,342 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 9,942 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| April 06, 2022 Filed Apr 8, 2022 21:37 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 912 | $29.69 | $27,077.28 |
DisclosureSEC source: 0001415889-22-003970 · form4-04082022_020427.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,876 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 2,000 shares of restricted stock, the grant of which was previously reported. Read SEC document |
| March 28, 2022 Filed Mar 30, 2022 20:10 UTC | ANI PHARMACEUTICALS INC ANIP · Entity 4638 | Tax withholdingCommon Stock | 1,420 | $28.17 | $40,001.40 |
DisclosureSEC source: 0001415889-22-003471 · form4-03302022_010309.xml · nonDerivative · entry 1 CAREY STEPHEN P. · CIK 0001674236 · SENIOR VICE PRESIDENT AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,788 F1 · kind: Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,113 shares of restricted stock, the grant of which was previously reported. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.